Analyze Diet
Journal of veterinary pharmacology and therapeutics2021; 45(1); 63-68; doi: 10.1111/jvp.13029

Pharmacokinetics of fluoxetine in horses following oral administration.

Abstract: This study aimed to investigate pharmacokinetics of fluoxetine in horses and validate a method for liquid chromatography mass spectrometry analysis of serum levels. Fluoxetine pharmacokinetics were determined using 10 healthy, adult horses. Fluoxetine pharmacokinetics following a single oral dose (0.25 mg/kg) were determined using blood samples collected prior to and at several time points over 7 days following administration. Serum concentrations of fluoxetine and its bioactive metabolite norfluoxetine were measured using liquid chromatography coupled to an accurate mass/high-resolution mass spectrometer. Pharmacokinetic parameters were estimated using a noncompartmental model. Time to maximum serum concentration and serum half-life of fluoxetine was 1.5 and 15.6 h, respectively. Steady-state serum concentrations were evaluated using five horses each receiving fluoxetine (0.25 mg/kg, PO, q24hrs) for 8 weeks and were found to be 62.9 ± 25.5 ng/ml on average. Norfluoxetine was not detected in any sample.
Publication Date: 2021-11-07 PubMed ID: 34747024DOI: 10.1111/jvp.13029Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the way fluoxetine, a common antidepressant, behaves once ingested by horses, and tests a method for measuring fluoxetine levels in the bloodstream.

Research methodology

The researchers carefully designed their study:

  • To find out how fluoxetine processes within a horse’s body, they gave an oral dose of the drug (0.25 mg/kg) to ten healthy, adult horses.
  • Blood samples were collected from the horses at specific intervals over a week following drug administration. This allowed researchers to track how much of the drug was present in the bloodstream at different times, getting insights into how quickly it is absorbed, processed, and eliminated from the body.
  • In five horses, the collection of blood samples continued for eight weeks to evaluate what the steady levels of fluoxetine would be in the blood after continuous daily doses.
  • The blood samples were then analyzed using a technique called liquid chromatography coupled to an accurate mass/high-resolution mass spectrometer. This is a highly sensitive method that can accurately measure the levels of substances, like fluoxetine, in samples.
  • The levels of not just fluoxetine, but also norfluoxetine (a metabolite or breakdown product of fluoxetine) were measured.

Key findings

The detailed process allowed the researchers to discover pharmacokinetic parameters:

  • They found that the time to reach maximum fluoxetine concentration in the horse’s blood was about 1.5 hours. This is a measure of how quickly the drug is absorbed into the bloodstream.
  • The half-life of fluoxetine, or how long it took for half the drug to be eliminated from the body, was around 15.6 hours. This demonstrated how slowly the drug is processed and removed from the body.
  • The researchers calculated that, after eight weeks of daily doses, the average steady levels of fluoxetine in the horses’ blood was about 62.9 ng/ml. This suggested the drug reached a stable concentration in the bloodstream over prolonged administration periods.
  • Interestingly, they did not detect norfluoxetine in any of the blood samples, suggesting that in horses, fluoxetine may not break down into this metabolite as it does in other species.

These findings give important insights into how fluoxetine behaves in horses, which could have implications for its use as a treatment in equine medicine. The method of liquid chromatography mass spectrometry analysis was also validated through this study, providing a reliable way of measuring drug concentration in horse serum.

Cite This Article

APA
Waitt Wolker LH, Veltri CA, Pearman K, Lozoya M, Norris JW. (2021). Pharmacokinetics of fluoxetine in horses following oral administration. J Vet Pharmacol Ther, 45(1), 63-68. https://doi.org/10.1111/jvp.13029

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 45
Issue: 1
Pages: 63-68

Researcher Affiliations

Waitt Wolker, Laura H
  • Department of Equine Medicine and Surgery, College of Veterinary Medicine, Midwestern University, Glendale, Arizona, USA.
Veltri, Charles A
  • Pharmaceutical Sciences Department, College of Pharmacy-Glendale, Midwestern University, Glendale, Arizona, USA.
Pearman, Krista
  • Department of Pharmacology, College of Graduate Studies, Midwestern University, Glendale, Arizona, USA.
Lozoya, Maria
  • Pharmaceutical Sciences Department, College of Pharmacy-Glendale, Midwestern University, Glendale, Arizona, USA.
Norris, Jeffrey W
  • Department of Pharmacology, College of Graduate Studies, Midwestern University, Glendale, Arizona, USA.

MeSH Terms

  • Administration, Oral
  • Animals
  • Chromatography, Liquid / veterinary
  • Fluoxetine
  • Half-Life
  • Horses
  • Mass Spectrometry / veterinary

Grant Funding

  • Midwestern University

References

This article includes 28 references
  1. Albright JD, Mohammed HO, Heleski CR, Wickens CL, Houpt KA. Crib-biting in US horses: Breed predispositions and owner perceptions of aetiology. Equine Veterinary Journal 41(5), 455-458.
    doi: 10.2746/042516409x372584google scholar: lookup
  2. Alegete P, Kancherla P, Albaseer SS, Boodida S. A fast and reliable LC-MS/MS method for simultaneous quantitation of fluoxetine and mirtazapine in human plasma. Analytical Methods 6(18), 7407-7414.
    doi: 10.1039/c4ay01057dgoogle scholar: lookup
  3. Altamura AC, Moro AR, Percudani M. Clinical pharmacokinetics of fluoxetine. Clinical Pharmacokinetics 26(3), 201-214.
  4. Archer DC, Freeman DE, Doyle AJ, Proudman CJ, Edwards GB. Association between cribbing and entrapment of the small intestine in the epiploic foramen in horses: 68 cases (1991-2002). Journal of the American Veterinary Medical Association 224(4), 562-564.
  5. Archer DC, Pinchbeck GK, French NP, Proudman CJ. Risk factors for epiploic foramen entrapment colic: an international study. Equine Veterinary Journal 40(3), 224-230.
    doi: 10.2746/042516408x266079google scholar: lookup
  6. Archer DC, Proudman CJ, Pinchbeck G, Smith JE, French NP, Edwards GB. Entrapment of the small intestine in the epiploic foramen in horses: A retrospective analysis of 71 cases recorded between 1991 and 2001. The Veterinary Record 155(25), 793-797.
  7. Blázquez A, Mas S, Plana MT, Gassó P, Méndez I, Torra M, Arnaiz JA, Lafuente A, Lázaro L. Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder. Journal of Clinical Psychopharmacology 34(3), 318-326.
  8. Ciribassi J, Luescher A, Pasloske KS, Robertson-Plouch C, Zimmerman A, Kaloostian-Whittymore L. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. American Journal of Veterinary Research 64(8), 994-998.
    doi: 10.2460/ajvr.2003.64.994google scholar: lookup
  9. Corado CR, McKemie DS, Knych HK. Dextromethorphan and debrisoquine metabolism and polymorphism of the gene for cytochrome P450 isozyme 2D50 in Thoroughbreds. American Journal of Veterinary Research 77(9), 1029-1035.
    doi: 10.2460/ajvr.77.9.1029google scholar: lookup
  10. Davis JL, Schirmer J, Medlin E. Pharmacokinetics, pharmacodynamics and clinical use of trazodone and its active metabolite m-chlorophenylpiperazine in the horse. Journal of Veterinary Pharmacology and Therapeutics 41(3), 393-401.
    doi: 10.1111/jvp.12477google scholar: lookup
  11. DiMaio Knych HK, Stanley SD. Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver. Biochemical Pharmacology 76(7), 904-911.
    doi: 10.1016/j.bcp.2008.07.016google scholar: lookup
  12. Escalona EE, Okell CN, Archer DC. Prevalence of and risk factors for colic in horses that display crib-biting behaviour. BMC Veterinary Research 10(Suppl 1), S3.
  13. Fuller RW, Wong DT. Serotonin reuptake blockers in vitro and in vivo. Journal of Clinical Psychopharmacology 7(6 Suppl), 36s-43s.
  14. Gretler SR, Finno CJ, Kass PH, Knych HK. Functional phenotyping of the CYP2D6 probe drug codeine in the horse. BMC Veterinary Research 17(1), 77.
  15. Hemeryck A, Belpaire FM. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An update. Current Drug Metabolism 3(1), 13-37.
    doi: 10.2174/1389200023338017google scholar: lookup
  16. Hiemke C, Bergemann N, Clement H, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Baumann P. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017. Pharmacopsychiatry 51(1-02), 9-62.
    doi: 10.1055/s-0043-116492google scholar: lookup
  17. Hillyer MH, Taylor FG, Proudman CJ, Edwards GB, Smith JE, French NP. Case control study to identify risk factors for simple colonic obstruction and distension colic in horses. Equine Veterinary Journal 34(5), 455-463.
  18. Kaur G, Voith VL, Schmidt PL. The use of fluoxetine by veterinarians in dogs and cats: A preliminary survey. Vet Rec Open 3(1), e000146.
  19. Knych HK, Mama KR, Steffey EP, Stanley SD, Kass PH. Pharmacokinetics and selected pharmacodynamics of trazodone following intravenous and oral administration to horses undergoing fitness training. American Journal of Veterinary Research 78(10), 1182-1192.
    doi: 10.2460/ajvr.78.10.1182google scholar: lookup
  20. Kondratenko SN, Savelyeva MI, Kukes VG, Shikh EV, Gneushev ET. Experimental and clinical pharmacokinetics of fluoxetine and amitriptyline: Comparative analysis and possible methods of extrapolation. Bulletin of Experimental Biology and Medicine 167(3), 356-362.
  21. Lebelt D, Zanella AJ, Unshelm J. Physiological correlates associated with cribbing behaviour in horses: Changes in thermal threshold, heart rate, plasma beta-endorphin and serotonin. Equine Veterinary Journal Supplement 27, 21-27.
  22. Litva A, Robinson CS, Archer DC. Exploring lay perceptions of the causes of crib-biting/windsucking behaviour in horses. Equine Veterinary Journal 42(4), 288-293.
  23. Malamed R, Berger J, Bain MJ, Kass P, Spier SJ. Retrospective evaluation of crib-biting and windsucking behaviours and owner-perceived behavioural traits as risk factors for colic in horses. Equine Veterinary Journal 42(8), 686-692.
  24. McGreevy P. Equine behavior: A guide for veterinarians and equine scientists (2nd ed.). .
  25. Robinson NE, SPrayberry K. Current therapy in equine medicine. .
  26. Scantlebury CE, Archer DC, Proudman CJ, Pinchbeck GL. Management and horse-level risk factors for recurrent colic in the UK general equine practice population. Equine Veterinary Journal 47(2), 202-206.
    doi: 10.1111/evj.12276google scholar: lookup
  27. Waters AJ, Nicol CJ, French NP. Factors influencing the development of stereotypic and redirected behaviours in young horses: Findings of a four year prospective epidemiological study. Equine Veterinary Journal 34(6), 572-579.
  28. Zhang Y, Huo M, Zhou J, Xie S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine 99(3), 306-314.

Citations

This article has been cited 0 times.